How DnXT models multi-market submissions: a global core template, market variants that inherit and diverge deliberately, and a variance ledger that shows every difference at a glance.
Generic regulatory news feeds create triage debt. DnXT scores every guidance, approval and safety action against your actual portfolio — so surveillance becomes signal, not noise.
DnXT’s Predictive HAQ Readiness forecasts the health authority questions your submission is most likely to receive — before you submit — grounded in analysis of 1,000+ real agency questions.
A practical playbook for responding to FDA information requests: triage, discipline routing, drafting, QC — and where AI genuinely helps without crossing the GxP line.
Grouped submissions let one sequence serve multiple related FDA applications. Here is how the mechanics actually work — shared files, member sequences, metadata mirroring, and cumulative views.
Where every FDA form lives in an eCTD submission, why the dynamic XFA versions break standard PDF viewers, and how form leaves behave across sequence lifecycles.
The eCTD backbone is harmonized; everything that gets submissions rejected is regional. A country-by-country guide to Module 1, DTD versions, and validation differences.
License fees are the visible part of eCTD publishing cost — and often not the biggest part. An honest breakdown of what teams actually pay across software, services, validation, and hidden line items.
Training records are among the most common GxP inspection findings — usually a systems failure, not a people failure. Here’s what training management software has to do to fix that.
A pharmaceutical EDMS in 2026 is judged on Part 11 e-signatures, audit trails, and how far it extends beyond regulatory — into quality, clinical, training, and inspection readiness.
